NEWMONT CORP
NEMNYSE🏆 #117 by market capEarnings Oct 22US Equity
$116.94▲ $0.89 (+0.76%)
LiveTrack NEM
Get earnings, price moves & breaking news on Telegram
24h▲ 0.8%
7d—
14d—
30d—
ytd—
1y—
🏦Market Cap
$123.21B
Mid Cap
📈Revenue Growth (YoY)
+19.1%
Healthy
📊Gross Margin
54.5%
Healthy
💵FCF Margin
56.5%
Strong
⚖️P/S Ratio
5.7x
Fair
Otter Score
80
Good
NEWMONT CORP
NEMAnalyst Ratings
Price
$116.94
Total
37
Raised
11
Lowered
7
Avg PT
$136.83
H / L
$170 / $110
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
RBC Capital | Reiterated | Outperform | 2026-09-16 | $135.00 | +15.40% |
Bernstein | Reiterated | Outperform | 2026-09-09 | $144.00 | +23.10% |
Scotiabank | Reiterated | Sector Outperform | 2026-08-12 | $149.00 | +27.40% |
Barclays | Reiterated | Overweight | 2026-07-28 | $124.00 | +6.00% |
TD Cowen | Upgraded | Hold → Buy | 2026-07-14 | — | — |
B of A Securities | Reiterated | Buy | 2026-07-09 | — | — |
Jefferies | Reiterated | Buy | 2026-07-06 | $146.00 | +24.90% |
UBS | Reiterated | Buy | 2026-06-30 | $120.00 | +2.60% |
BMO Capital | Reiterated | Outperform | 2026-04-24 | $145.00 | +24.00% |
CIBC | Reiterated | Outperform | 2026-04-21 | $170.00 | +45.40% |
Citigroup | Reiterated | Buy | 2026-03-03 | — | — |
Freedom Broker | Reiterated | Buy | 2025-09-30 | — | — |
Raymond James | Reiterated | Outperform | 2025-09-23 | $140.00 | +19.70% |
Macquarie | Downgraded | Outperform → Neutral | 2025-09-02 | $72.00 | −38.40% |
JP Morgan | Upgraded | Neutral → Overweight | 2024-11-19 | — | — |
Argus Research | Upgraded | Hold → Buy | 2024-08-29 | $110.00 | −5.90% |
TD Securities | Reiterated | Hold | 2024-04-29 | $129.00 | +10.30% |
Goldman Sachs | Reiterated | Buy | 2023-04-21 | $104.30 | −10.80% |
Canaccord Genuity | Upgraded | Hold → Buy | 2023-03-14 | $60.00 | −48.70% |
Exane BNP Paribas | Upgraded | Neutral → Outperform | 2023-02-13 | — | — |
Credit Suisse | Downgraded | Outperform → Neutral | 2022-04-19 | — | — |
Deutsche Bank | Reiterated | Buy | 2020-06-17 | — | — |
B. Riley FBR | Reiterated | Buy | 2020-05-19 | — | — |
B. Riley Securities | Reiterated | Buy | 2020-05-19 | — | — |
B. Riley | Upgraded | Neutral → Buy | 2020-01-13 | — | — |
Citi | Upgraded | Neutral → Buy | 2019-05-23 | — | — |
Morgan Stanley | Upgraded | Equal Weight → Overweight | 2018-06-12 | — | — |
Argus | Downgraded | Buy → Hold | 2018-05-05 | — | — |
Bank of America | Reiterated | Buy | 2018-02-26 | — | — |
Standpoint Research | Upgraded | Hold → Buy | 2016-12-29 | — | — |
Mackie Research | Upgraded | Hold → Buy | 2016-10-31 | — | — |
Clarkson Capital Markets | Downgraded | Buy → Neutral | 2016-04-18 | — | — |
Clarksons Platou | Downgraded | Buy → Neutral | 2016-04-18 | — | — |
FBR Capital | Reiterated | Market Perform | 2016-01-28 | — | — |
HSBC | Downgraded | Buy → Hold | 2015-10-26 | — | — |
BB&T Capital | Downgraded | Buy → Hold | 2014-11-03 | — | — |
Cowen & Co. | Upgraded | Market Perform → Outperform | 2014-09-09 | — | — |
Institution
RBC Capital
Reiterated · Outperform · 2026-09-16
$135.00
+15.40%
Bernstein
Reiterated · Outperform · 2026-09-09
$144.00
+23.10%
Scotiabank
Reiterated · Sector Outperform · 2026-08-12
$149.00
+27.40%
Barclays
Reiterated · Overweight · 2026-07-28
$124.00
+6.00%
TD Cowen
Upgraded · Hold → Buy · 2026-07-14
—
—
B of A Securities
Reiterated · Buy · 2026-07-09
—
—
Jefferies
Reiterated · Buy · 2026-07-06
$146.00
+24.90%
UBS
Reiterated · Buy · 2026-06-30
$120.00
+2.60%
BMO Capital
Reiterated · Outperform · 2026-04-24
$145.00
+24.00%
CIBC
Reiterated · Outperform · 2026-04-21
$170.00
+45.40%
Citigroup
Reiterated · Buy · 2026-03-03
—
—
Freedom Broker
Reiterated · Buy · 2025-09-30
—
—
Raymond James
Reiterated · Outperform · 2025-09-23
$140.00
+19.70%
Macquarie
Downgraded · Outperform → Neutral · 2025-09-02
$72.00
−38.40%
JP Morgan
Upgraded · Neutral → Overweight · 2024-11-19
—
—
Argus Research
Upgraded · Hold → Buy · 2024-08-29
$110.00
−5.90%
TD Securities
Reiterated · Hold · 2024-04-29
$129.00
+10.30%
Goldman Sachs
Reiterated · Buy · 2023-04-21
$104.30
−10.80%
Canaccord Genuity
Upgraded · Hold → Buy · 2023-03-14
$60.00
−48.70%
Exane BNP Paribas
Upgraded · Neutral → Outperform · 2023-02-13
—
—
Credit Suisse
Downgraded · Outperform → Neutral · 2022-04-19
—
—
Deutsche Bank
Reiterated · Buy · 2020-06-17
—
—
B. Riley FBR
Reiterated · Buy · 2020-05-19
—
—
B. Riley Securities
Reiterated · Buy · 2020-05-19
—
—
B. Riley
Upgraded · Neutral → Buy · 2020-01-13
—
—
Citi
Upgraded · Neutral → Buy · 2019-05-23
—
—
Morgan Stanley
Upgraded · Equal Weight → Overweight · 2018-06-12
—
—
Argus
Downgraded · Buy → Hold · 2018-05-05
—
—
Bank of America
Reiterated · Buy · 2018-02-26
—
—
Standpoint Research
Upgraded · Hold → Buy · 2016-12-29
—
—
Mackie Research
Upgraded · Hold → Buy · 2016-10-31
—
—
Clarkson Capital Markets
Downgraded · Buy → Neutral · 2016-04-18
—
—
Clarksons Platou
Downgraded · Buy → Neutral · 2016-04-18
—
—
FBR Capital
Reiterated · Market Perform · 2016-01-28
—
—
HSBC
Downgraded · Buy → Hold · 2015-10-26
—
—
BB&T Capital
Downgraded · Buy → Hold · 2014-11-03
—
—
Cowen & Co.
Upgraded · Market Perform → Outperform · 2014-09-09
—
—
One row per institution · price target from the firm's latest published target
StockOtter · stockotter.space